Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control
出版年份 2021 全文链接
标题
Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 9, Pages 4374
出版商
MDPI AG
发表日期
2021-04-23
DOI
10.3390/ijms22094374
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Treatment of Diabetic Kidney Disease: Current and Future
- (2021) Tomotaka Yamazaki et al. Diabetes & Metabolism Journal
- Assessing the Risk for Gout With Sodium–Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes
- (2020) Michael Fralick et al. ANNALS OF INTERNAL MEDICINE
- Inflammatory Targets in Diabetic Nephropathy
- (2020) Javier Donate-Correa et al. Journal of Clinical Medicine
- Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
- (2020) Lucas Opazo-Ríos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Nifedipine Upregulates ATF6-α, Caspases -12, -3, and -7 Implicating Lipotoxicity-Associated Renal ER Stress
- (2020) Chiung-Chi Peng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via PPARα in vivo and in vitro
- (2020) Dan Wei et al. LIFE SCIENCES
- Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy
- (2020) Lucas Opazo-Ríos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Uric acid and risk of diabetic kidney disease
- (2020) Michael Mauer et al. JOURNAL OF NEPHROLOGY
- The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction
- (2020) Mengyuan Ge et al. Frontiers in Physiology
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities
- (2020) Pei-Hui Lin et al. Frontiers in Physiology
- Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors
- (2020) Rosalie A. Scholtes et al. NEPHROLOGY
- ATF6α downregulation of PPARα promotes lipotoxicity-induced tubulointerstitial fibrosis
- (2019) Tzu-Ming Jao et al. KIDNEY INTERNATIONAL
- Uric acid and the cardio‐renal effects of SGLT2 inhibitors
- (2019) Clifford J. Bailey DIABETES OBESITY & METABOLISM
- What does sodium‐glucose co‐transporter 1 inhibition add: Prospects for dual inhibition
- (2019) Jessica A. Dominguez Rieg et al. DIABETES OBESITY & METABOLISM
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 Diabetes
- (2019) Chan Heo et al. Journal of Clinical Medicine
- Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging
- (2019) Kengo Kidokoro et al. CIRCULATION
- Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death
- (2019) Ryo Shibusawa et al. Scientific Reports
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipragliflozin Ameliorates Endoplasmic Reticulum Stress and Apoptosis through Preventing Ectopic Lipid Deposition in Renal Tubules
- (2019) Kohshiro Hosokawa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice
- (2018) Dong Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
- (2018) Hiddo J.L. Heerspink et al. KIDNEY INTERNATIONAL
- Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet
- (2018) Susumu Takagi et al. Journal of Diabetes Investigation
- Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
- (2018) Yan Xie et al. KIDNEY INTERNATIONAL
- SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney
- (2018) Muriel Auberson et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Emerging role of Unfolded Protein Response (UPR) mediated proteotoxic apoptosis in diabetes
- (2018) Vivek Kumar Pandey et al. LIFE SCIENCES
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8
- (2018) Yumi Takiyama et al. EBioMedicine
- Predictive Value of Cortical Thickness Measured by Ultrasonography for Renal Impairment: A Longitudinal Study in Chronic Kidney Disease
- (2018) Shotaro Hoi et al. Journal of Clinical Medicine
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uric acid causes kidney injury through inducing fibroblast expansion, Endothelin-1 expression, and inflammation
- (2017) Muhammad Mansyur Romi et al. BMC Nephrology
- Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
- (2017) T Avril et al. Oncogenesis
- Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus
- (2016) Hiroyuki Tanaka et al. ADVANCES IN THERAPY
- Lipotoxicity as a trigger factor of renal disease
- (2016) Adriana Izquierdo-Lahuerta et al. JOURNAL OF NEPHROLOGY
- Mitochondrial dysfunction in obesity-related kidney disease: a novel therapeutic target
- (2016) Chengyuan Tang et al. KIDNEY INTERNATIONAL
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition
- (2015) Giulia Ferrannini et al. DIABETES CARE
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
- (2015) Tahir Kanji et al. BMC Nephrology
- Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?
- (2015) Jose Górriz et al. Journal of Clinical Medicine
- The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years
- (2015) Alberto Martínez-Castelao et al. Journal of Clinical Medicine
- SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
- (2014) Yukihiro Chino et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Functional Role of Glucose Metabolism, Osmotic Stress, and Sodium-Glucose Cotransporter Isoform-Mediated Transport on Na+/H+ Exchanger Isoform 3 Activity in the Renal Proximal Tubule
- (2014) T. D. Pessoa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Sodium–glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?
- (2013) Richard E. Gilbert KIDNEY INTERNATIONAL
- Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
- (2013) Bhadran Bose et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat
- (2011) Scott C. Thomson et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biology of Human Sodium Glucose Transporters
- (2011) Ernest M. Wright et al. PHYSIOLOGICAL REVIEWS
- Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus
- (2009) B Komoroski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Tubuloglomerular feedback: mechanistic insights from gene-manipulated mice
- (2008) Jurgen Schnermann et al. KIDNEY INTERNATIONAL
- Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15)
- (2008) H. Yokoyama et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now